Advertisement
News
Advertisement

Millennium adding two cancer programs via Intellikine buy

Wed, 12/21/2011 - 7:47am
Mass High Tech: The Journal of New England Technology

Millennium: The Takeda Oncology Company will add two cancer drug candidates as part of Japanese parent Takeda Pharmaceutical Company Ltd.’s acquisition of Intellikine Inc. of La Jolla, Calif., Takeda said today.

SOURCE

Topics

Advertisement

Share this Story

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading